| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.088 | 0.05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.083 | 0.07 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.048 | 0.3 |